Constantinos Mavroidis, Distinguished Professor of Engineering, discusses the impact 3-D printing will have on the biomedical field. His lab is already using the technology to print smart, customized orthotic devices.
Northeastern’s Professional Science Master’s degree program in biotechnology, now in its 10th year, is a model for similar programs around the world.
A team of engineering students conceived a smart toothbrush at the annual Engineers for the Greater Good competition, winning first place and a $1,500 stipend to turn the concept into reality.
During its 40-year history, the Barnett Institute of Chemical and Biological Analysis has pioneered breakthroughs in biotechnology, forensic science, and advanced materials study. Last week, its accomplishments were honored at a daylong conference on campus.
Pharmaceutical sciences professor Barbara Waszczak and graduate student Brendan Harmon devised an intranasal gene therapy that targets the underlying cause of Parkinson’s disease, not just its symptoms.
The leaders of the Northeastern Biochemistry club attribute its success to strong friendships and a deep interest in the field.
In a new paper, Distinguished Professor Mansoor Amiji and his collaborators present a drug-delivery system they believe can specifically target only tumors and turn off the cancer cells’ “superpowers” that allow them to grow uncontrollably.
Professor Ahmed Busnaina’s method of directed assembly is faster, cheaper, and more versatile than traditional 3-D printing. What does it mean? Could $10 iPhones and tissue engineering breakthroughs be just the tip of the iceberg. Photo by Mary Knox Merrill.
Vladimir Torchilin, Distinguished Professor of pharmaceutical sciences, has earned a lifetime achievement award for his outstanding contributions to the field of targeted drug delivery.
Northeastern’s unique Lab to Ventures program guides top graduate students through the process of turning their research into independent, successful companies.
Complex decision-making requires us to select the most important information and throw out the rest, according to John Coley, an associate professor of psychology.
For decades, the inner workings of a protein implicated in the cause of nearly 30 percent of all cancers baffled drug developers. But chemistry professor Carla Mattos may have unlocked the mystery.